![Claire Giraut](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Claire Giraut
Direktor/Vorstandsmitglied bei
EUROAPI
Vermögen: 884 $ am 31.05.2026
Profil
Claire Giraut is currently an Independent Director at EUROAPI SA since 2022 and a Director at Bank Julius Bär & Co. AG since 2010.
Former positions include Independent Director at Heurtey Petrochem SA from 2014 to 2016, Independent Director at DBV Technologies SA from 2016 to 2021, Independent Non-Executive Director at Julius Bär Gruppe AG from 2010 to 2022, Independent Director at Grifols SA in 2024, Chief Financial Officer & Head-Communications at Coflexip Stena Offshore from 1997 to 2001, Chief Financial Officer & EVP-Administration at Ipsen SA from 2009 to 2011, Chief Financial Officer at Serete Group from 1985 to 1996, Chief Financial Officer & Vice President at bioMérieux SA from 2014 to 2018, Chief Financial Officer at Ipsen Pharma SA from 2010 to 2011, Chief Financial Officer at Europcar Mobility Group SA from 2011 to 2012, Legal Manager at Wallingstown Co. Ltd., Chief Financial Officer-Offshore Branch at Technip-Coflexip U.K Holdings Ltd. from 2002 to 2003, and Financial Controller at France Bar Association from 1996 to 1997.
Education includes graduation from Institut National Agronomique Paris-Grignon in 1978 and AgroParisTech in 1978.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2024 | 509 ( 0% ) | 884 $ | 31.05.2026 |
Aktive Positionen von Claire Giraut
| Unternehmen | Position | Beginn |
|---|---|---|
| EUROAPI | Direktor/Vorstandsmitglied | 06.05.2022 |
Bank Julius Bär & Co. AG
 Bank Julius Bär & Co. AG Investment ManagersFinance BJB’s investment approach is founded on a four-step investment process through which they aim to manage risk and returns in a systematic way. | Direktor/Vorstandsmitglied | 01.01.2010 |
Ehemalige bekannte Positionen von Claire Giraut
| Unternehmen | Position | Ende |
|---|---|---|
| GRIFOLS, S.A. | Direktor/Vorstandsmitglied | 12.07.2024 |
| JULIUS BÄR GRUPPE AG | Direktor/Vorstandsmitglied | 12.04.2022 |
| DBV TECHNOLOGIES | Direktor/Vorstandsmitglied | 22.03.2021 |
| BIOMÉRIEUX | Finanzdirektor/CFO | 28.02.2018 |
| HEURTEY PETROCHEM | Direktor/Vorstandsmitglied | 01.03.2016 |
Ausbildung von Claire Giraut
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Coflexip Stena Offshore
 Coflexip Stena Offshore Engineering & ConstructionIndustrial Services Provides engineering, technology and construction services for oil and gas, petrochemicals and other industries. | Industrial Services |
Grifols SA
 Grifols SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals, diagnostic and bio supplies | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Heurtey Petrochem SA
 Heurtey Petrochem SA Industrial MachineryProducer Manufacturing Designs and manufactures process furnaces, waste heat recovery units and related equipment for refining, petrochemical, syngas & hydrogen markets | Producer Manufacturing |
Bank Julius Bär & Co. AG
Bank Julius Bär & Co. AG Investment ManagersFinance BJB’s investment approach is founded on a four-step investment process through which they aim to manage risk and returns in a systematic way. | Finance |
Serete Group
 Serete Group Engineering & ConstructionIndustrial Services Provides engineering services | Industrial Services |
bioMérieux SA
 bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Ipsen Pharma SA
 Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Europcar Mobility Group SA
 Europcar Mobility Group SA Finance/Rental/LeasingFinance Provides car rental services | Finance |
Institut National Agronomique Paris-Grignon
 Institut National Agronomique Paris-Grignon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Julius Bär Gruppe AG
 Julius Bär Gruppe AG Financial ConglomeratesFinance Provides wealth management services | Finance |
Wallingstown Co. Ltd.
 Wallingstown Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Technip-Coflexip U.K Holdings Ltd.
 Technip-Coflexip U.K Holdings Ltd. Engineering & ConstructionIndustrial Services Operates as a holding company with interest in construction services | Industrial Services |
AgroParisTech
 AgroParisTech Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
France Bar Association | |
EUROAPI SA
 EUROAPI SA BiotechnologyHealth Technology Develops, manufactures, markets and distributes small molecule APIs | Health Technology |
